|
⚲
|
| Curaxis Pharmaceutical Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001170723 |
| Sale | 2010-02-05 ($1.5 M Offered, $1.5 M Sold) |
| Fund | |
| Phone | 6785663750 |
| Address | 12600 Deerfield Parkway Alpharetta, 30004 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Judy Geaslen | |
| William McConville | |
| David Corcoran | |
| Ronald Pompeo | |
| Sheldon Goldberg | |
| Patrick Smith |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Lousada Max
✚
|
0.0 | |
|
Love Kathleen
✚
|
0.0 | |
|
Loveman Gary W
✚
|
0.0 | |
|
LU-0610 Gaingels Fund I, a series of Zachary Ginsburg Funds,
✚
|
0.0 | |
|
Lubert-Adler Independence Portfolio Investors, L.P.
✚
|
0.0 | |
|
Lucas Brand Equity LP
✚
|
0.0 | |
|
Lucas DFW, LLC
✚
|
0.0 | |
|
Lucas Venture Group VI, LP
✚
|
0.0 | |
|
Lucas Venture Group XLVIII, LLC
✚
|
0.0 | |
|
Levenson Julie
✚
|
0.0 |